Legend Biotech Corporation
LEGN
$27.75
$1.063.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 272.31M | 255.06M | 194.96M | 186.30M | 159.92M |
| Total Other Revenue | 18.00K | 3.00K | 90.00K | 224.00K | 281.00K |
| Total Revenue | 272.33M | 255.06M | 195.05M | 186.52M | 160.21M |
| Cost of Revenue | 228.45M | 196.29M | 173.27M | 178.35M | 150.99M |
| Gross Profit | 43.88M | 58.77M | 21.79M | 8.17M | 9.21M |
| SG&A Expenses | 87.33M | 80.65M | 72.43M | 83.13M | 79.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 315.78M | 276.94M | 245.70M | 261.48M | 230.56M |
| Operating Income | -43.45M | -21.88M | -50.65M | -74.96M | -70.36M |
| Income Before Tax | -39.07M | -124.80M | -99.13M | 40.51M | -120.89M |
| Income Tax Expenses | 616.00K | 582.00K | 1.79M | 14.23M | 4.44M |
| Earnings from Continuing Operations | -39.69M | -125.38M | -100.92M | 26.28M | -125.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.69M | -125.38M | -100.92M | 26.28M | -125.32M |
| EBIT | -43.45M | -21.88M | -50.65M | -74.96M | -70.36M |
| EBITDA | -41.53M | -19.50M | -48.24M | -72.06M | -69.23M |
| EPS Basic | -0.43 | -1.36 | -1.10 | 0.29 | -1.37 |
| Normalized Basic EPS | -0.13 | -0.42 | -0.33 | 0.15 | -0.41 |
| EPS Diluted | -0.44 | -1.36 | -1.10 | 0.29 | -1.37 |
| Normalized Diluted EPS | -0.13 | -0.42 | -0.33 | 0.14 | -0.41 |
| Average Basic Shares Outstanding | 184.64M | 184.14M | 183.76M | 183.32M | 183.28M |
| Average Diluted Shares Outstanding | 92.32M | 92.07M | 91.88M | 100.70M | 91.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |